Forecast & Rating9 analysts currently cover RAPT Therapeutics, with about 0.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $58.00, about 0.0% downside from the current price of $58.02. Historically, about 16.2% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on RAPT Therapeutics's outlook. Data as of Mar 3, 2026; for reference only and not investment advice.
Feb 20, 2026
Price forecast
$58.00-0.03%
Forecast & RatingHold
9analysts
Strong buy0.00%
Buy0.00%
Hold100.00%
Sell0.00%
Strong sell0.00%
Strong buy
0
Buy
0
Hold
9
Sell
0
Strong sell
0
Target price forecast
Forecast baselineMar 1, 2026
Forecast met19.7%
Stock price$58.02
Average forecast price$65.0
Highest forecast price$72
Lowest forecast price$56
Average forecast price
$65.0
Highest forecast price
$72
Lowest forecast price
$56
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.